EverSource Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Sell
612
-1,664
-73% -$39K ﹤0.01% 2638
2026
Q1
$31.9K Sell
2,276
-220
-9% -$2.96K ﹤0.01% 2211
2025
Q4
$28K Buy
2,496
+1,423
+133% +$16.3K ﹤0.01% 2161
2025
Q3
$12.4K Sell
1,073
-589
-35% -$6.9K ﹤0.01% 2695
2025
Q2
$20.3K Buy
1,662
+1,504
+952% +$18.9K ﹤0.01% 2273
2025
Q1
$2.26K Sell
158
-5
-3% -$78 ﹤0.01% 2870
2024
Q4
$2.6K Buy
163
+25
+18% +$495 ﹤0.01% 2617
2024
Q3
$3.32K Hold
138
﹤0.01% 2383
2024
Q2
$3.3K Hold
138
﹤0.01% 2368
2024
Q1
$2.5K Sell
138
-80
-37% -$1.55K ﹤0.01% 2313
2023
Q4
$4.89K Buy
218
+130
+148% +$2.68K ﹤0.01% 1873
2023
Q3
$1.78K Sell
88
-7
-7% -$159 ﹤0.01% 2045
2023
Q2
$2.43K Sell
95
-11
-10% -$290 ﹤0.01% 1974
2023
Q1
$3.15K Hold
106
﹤0.01% 1801
2022
Q4
$2.87K Buy
106
+85
+405% +$2.08K ﹤0.01% 1804
2022
Q3
$0 Sell
21
-133
-86% -$3.48K ﹤0.01% 1971
2022
Q2
$4K Sell
154
-273
-64% -$7.84K ﹤0.01% 1307
2022
Q1
$14K Buy
427
+406
+1,933% +$13.1K ﹤0.01% 832
2021
Q4
$1K Buy
+21
New +$679 ﹤0.01% 1680

Other funds holding AVNS

EverSource Wealth Advisors's AVNS Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Avanos Medical (AVNS) stake by 73% in Q2 2026, selling an estimated $39K and leaving 612 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

EverSource Wealth Advisors first reported a position in AVNS in Q4 2021 and has held it in 19 quarters since. The position peaked at $31.9K in Q1 2026. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • EverSource Wealth Advisors held 612 shares of Avanos Medical worth $15.2K as of Q2 2026.
  • EverSource Wealth Advisors sold 1,664 Avanos Medical shares in Q2 2026, an estimated $39K.
  • Avanos Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2638 holding.
  • EverSource Wealth Advisors first reported a position in Avanos Medical in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Avanos Medical position peaked at $31.9K in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.